What are the different classifications of opioids, and can you provide a tabular format with representative examples for each class?

Opioid Classifications

Opioids are classified into three main systems: by analgesic potency (WHO ladder), by receptor activity, and by chemical structure. 1

Classification Systems

1. By Analgesic Potency (WHO Ladder Classification)

This is the most clinically relevant classification system for pain management 2, 3:

WHO Level	Pain Severity	Examples	Key Characteristics
Level II: Weak Opioids	Moderate pain	• Codeine • Tramadol • Dihydrocodeine • Hydrocodone • Dextropropoxyphene	• Relative potency 0.1-0.2 compared to oral morphine • Maximum daily doses apply • Often combined with acetaminophen or NSAIDs • Duration 2-12 hours depending on formulation [4,3]
Level III: Strong Opioids	Moderate to severe pain	• Morphine (gold standard) • Oxycodone • Hydromorphone • Fentanyl • Methadone • Oxymorphone • Buprenorphine	• No upper dose limit (except buprenorphine) • Relative potency 1-100 compared to oral morphine • Various routes available • Duration 2-120 hours depending on agent [4,2,3]

2. By Receptor Activity (Pharmacological Classification)

This classification is critical because drugs from different categories should NEVER be prescribed simultaneously 1:

Receptor Type	Mechanism	Examples	Clinical Notes
Pure Agonists	Full activation of μ-opioid receptors	• Morphine • Fentanyl • Oxycodone • Hydromorphone • Methadone • Codeine • Tramadol • Hydrocodone • Oxymorphone	• Most commonly used • Predictable dose-response • No ceiling effect for analgesia • Standard for severe pain [2,3]
Partial Agonists	Partial activation of μ-receptors with ceiling effect	• Buprenorphine	• Maximum dose 4 mg oral, 3 mg IV • Ceiling effect limits respiratory depression • High receptor affinity can block full agonists • Duration up to 8 hours [4,5]
Mixed Agonist-Antagonists	Agonist at κ-receptors, antagonist at μ-receptors	• Nalbuphine • Butorphanol	• Can precipitate withdrawal in opioid-dependent patients • Ceiling effect for analgesia • Lower abuse potential • NOT recommended for cancer pain [5,2]
Antagonists	Block opioid receptors	• Naloxone • Naltrexone • Alvimopan • Naloxegol • Naldemedine	• Reverse opioid effects • Peripherally-acting antagonists (alvimopan, naloxegol) treat constipation without blocking analgesia • Duration varies by route and dose [5]

3. By Chemical Structure

Chemical Class	Examples	Distinguishing Features
Natural Alkaloids	• Morphine • Codeine	• Derived from opium poppy • Morphine is prototype for comparison [6]
Semi-synthetic	• Hydromorphone • Oxycodone • Hydrocodone • Oxymorphone • Buprenorphine	• Chemical modifications of natural opioids • Improved pharmacokinetics [6]
Synthetic	• Fentanyl • Methadone • Tramadol • Tapentadol • Meperidine	• Entirely laboratory-created • Diverse structures and properties • Meperidine NOT recommended due to toxic metabolites [5,2]

Equianalgesic Dosing Reference

Critical for safe opioid rotation 2, 7:

Opioid	Parenteral Dose	Oral Dose	IV to PO Factor	Duration	MME Conversion
Morphine	10 mg	30 mg	3	3-4 h	1
Hydromorphone	1.5 mg	7.5 mg	2.5-5	2-3 h	4
Oxycodone	—	15-20 mg	—	3-5 h	1.5
Hydrocodone	—	30-45 mg	—	3-5 h	1
Fentanyl (IV)	0.1-0.25 mg	—	—	—	—
Fentanyl (transdermal)	—	—	—	72 h	2.4 per μg/h
Methadone	Variable	Variable	Variable	15-120 h	4-12 (dose-dependent)
Codeine	—	200 mg	—	3-4 h	0.15
Tramadol	—	300 mg	—	6 h	0.1
Tapentadol	—	75-100 mg	—	4-6 h	0.4
Oxymorphone	—	10 mg	10	3-6 h	3

Special Considerations by Agent

Agents to AVOID or Use with Extreme Caution:

• Meperidine: NOT recommended for cancer pain due to neurotoxic metabolite normeperidine, especially in renal insufficiency 5, 2
• Codeine/Tramadol: Contraindicated in children <12 years, post-tonsillectomy patients <18 years, and breastfeeding patients due to variable metabolism 8
• Mixed agonist-antagonists: NOT recommended for cancer pain 2

Renal Insufficiency Considerations:

Preferred agents (no active metabolites) 5:

• Fentanyl
• Sufentanil
• Methadone (requires experienced prescriber)

Avoid or use with extreme caution:

• Morphine (morphine-6-glucuronide accumulation) 2
• Codeine
• Hydrocodone
• Tramadol
• Meperidine

Special Properties:

Methadone 4, 2:

• Variable half-life (15-120 hours)
• Complex conversion ratios (factor 4-12 depending on baseline morphine dose)
• Requires specialist consultation if unfamiliar
• QT prolongation risk
• Typically dosed every 8-12 hours despite long half-life

Transdermal Fentanyl 4, 2:

• Reserved for stable opioid requirements ≥60 mg/day oral morphine equivalent
• NOT for rapid titration
• 1:1 conversion ratio when switching from IV fentanyl
• Reduced constipation compared to oral morphine

Buprenorphine 5:

• Decision to continue or hold perioperatively must be individualized
• Can be continued with supplemental full agonists for acute pain
• Multiple drug interactions including QT prolongation

Clinical Pitfalls

1. Never combine drugs from different receptor activity classes - can precipitate withdrawal or reduce analgesia 1

2. Methadone conversions are NOT linear - use lower conversion factors at higher baseline doses 2, 7

3. Transdermal fentanyl takes 12-24 hours to reach steady state - not appropriate for acute pain titration 2

4. Codeine is a prodrug - 10% of Caucasians are poor metabolizers and get no analgesia; ultra-rapid metabolizers risk toxicity 8

5. Tramadol has serotonergic activity - contraindicated with MAOIs, caution with SSRIs/SNRIs due to serotonin syndrome risk 1, 3